Show notes at http://www.pharmacyjoe.com/episode40
In this episode, I’ll discuss the recognition and treatment of serotonin syndrome (SS), malignant hyperthermia (MH), and neuroleptic malignant syndrome (NMS).
Muscular rigidity, significant hyperthermia, and autonomic instability are all common features of serotonin syndrome, malignant hyperthermia, and neuroleptic malignant syndrome. A thorough review of the patient’s current and recent medications is the best way to tell the difference between these 3 conditions.
Serotonin syndrome
Seretonin syndrome can result from an overdose or drug interaction involving one or more of the many drugs that increase serotonergic activity.
The Hunter Criteria is often used for the diagnosis of serotonin syndrome. To fulfill the Hunter Criteria, a patient must have taken a serotonergic agent and meet ONE of the following conditions:
1. Spontaneous clonus
2. Inducible clonus PLUS agitation or diaphoresis
3. Ocular clonus PLUS agitation or diaphoresis
4. Tremor PLUS hyperreflexia
5. Hypertonia PLUS temperature above 38ºC PLUS ocular clonus or inducible clonus
Serotonin syndrome is very similar to neuroleptic malignant syndrome. A thorough review of the patient’s current and recent medications and history of present illness is essential for differentiating between the two syndromes. SS develops over 24 hours, whereas NMS develops over a period of days. Serotonin syndrome is accompanied by neuromuscular hyperreactivity (tremor, hyperreflexia, and myoclonus); NMS is accompanied by sluggish neuromuscular responses (rigidity and bradyreflexia).
Cases of serotonin syndrome that I’ve seen have included an opioid plus two serotonergic medications. I once encountered a young adult female in my emergency department with confusion, hyperthermia, tachycardia, tremor, hyperreflexia, and diaphoresis. She was on therapeutic doses of citalopram and hydrocodone, but had taken three cyclobenzaprine 10 mg tablets for her severe back pain. The team initially thought she was having an anticholinergic reaction from the extra cyclobenzaprine. I was able to point out that the patient was diaphoretic so anticholinergic toxicity was unlikely, and that cyclobenzaprine is also a serotonergic agent (in fact it is structurally nearly identical to amitriptyline). We gave the patient cyprohpetadine and lorazepam and she recovered quickly.
Treatment of serotonin syndrome
In addition to supportive care, benzodiazepines are given to eliminate agitation, tremor, clonus, and elevations in heart rate and blood pressure. Start with 1 or 2 mg of IV lorazepam or midazolam and titrate the dose to effect. Cyproheptadine, an anti-serotonergic antihistamine can be given as well. Give 12 mg orally or by orogastric tube as the initial adult dose.